Volume 4, Emitir 8 (2014)
Atualização de pesquisa
How dementia and neurodegenerative disease clinical research networks have enhanced research delivery in England
Piers Kotting, Martin N Rossor, Ian G McKeith & John T OBrien
Resultados da Trilha Clínica
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Resultados da Trilha Clínica
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Resultados da Trilha Clínica
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Artigo de Revisão
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Metodologia da Trilha Clínica
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
